Early data provided evidence that NK and CD8 cells from XLP patients exhibited defective killing of EBV-infected B cells (55, 56); this was linked to impaired killing via 2B4/SLAMF4 and NTB-A/SLAMF6 (57–60). This evidence concerns the gene CD244 and X-linked lymphoproliferative disease.